Life Sciences

The New Regulation on Health Technology Assessment in the European Union

In January 2022, the new Regulation (EU) 2021/2282 of the European Parliament and the Council of the European Union of 15 December 2021 on health technology assessment (the "HTA Regulation") entered into force on the territory of the European Union. The HTA Regulation aims to harmonize (but not to fully centralize) the currently fragmented procedure for assessing the health technologies of innovative medical therapies entering the European Union market in different European countries. The HTA Regulation shall begin to apply in stages from 12 January 2025 and the European Commission has already approved an implementation plan until that date, which includes mainly the establishment of the information resources needed for its operation, the creation of new supranational bodies to participate in the application of the Regulation and training of the competent national authorities.

NNDKP and Wolf Theiss Advise on Marcos Provit EUR 8.5 Million Bond Issuance

Nestor Nestor Diculescu Kingston Petersen has advised Marcos Provit on its EUR 8.5 million cross-border corporate bond issuance through a private placement under the coordination of CVI Dom Maklerski. Wolf Theiss advised CVI.

WKB Advises Blirt on Sale of Shares to Qiagen

Wiercinski Kwiecinski Baehr has advised Blirt’s shareholders on the sale of a 96% stake to Qiagen. Wardynski & Partners reportedly advised Qiagen on the deal.

Filip & Company and Firon Bar-Nir Advise on Medicover’s Acquisition of Laurus Medical

Filip & Company has advised Medicover on its acquisition of Laurus Medical network of clinics. Firon Bar-Nir advised the seller.

MFW Fialek Advises PZU Zdrowie on Diagnostic Company Acquisition

MFW Fialek has advised PZU Zdrowie company Bonus-Diagnosta on its acquisition of an unidentified healthcare company specializing in diagnostic imaging.

Deal 5: Innova Capital Managing Director Tobiasz Jankowski on its Dental Sector Acquisitions

On February 10, 2022, CEE Legal Matters reported that Wiercinski Kwiecinski Baehr had advised Innova Capital Group's Innova 6 fund on its investment in three dental services companies: DPC, Pomorska Inicjatywa Medyczna, and Medicadent Stomatologia. CEE In-House Matters spoke with Tobiasz Jankowski, Managing Director at Innova Capital Group to learn more about the matter.

CMS Appoints Four New Partners and Two Equity Partners Across CEE

Following CMS's recent global promotion round, Nevena Radlova, Michal Andruszkiewicz, Cristina Popescu, and Olga Shenk were promoted to Partner, with Partners Gabriela Staber and Andrea Potz becoming Equity Partners.